These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 5681477)

  • 1. Treatment of multiple myeloma.
    Waldenström J
    Br J Haematol; 1968 Sep; 15(3):217-20. PubMed ID: 5681477
    [No Abstract]   [Full Text] [Related]  

  • 2. Myeloma proteins, Bence Jones proteins and normal immunoglobulins in multiple myeloma.
    Caggiano V; Cuttner J; Solomon A
    Blood; 1967 Sep; 30(3):265-87. PubMed ID: 6038301
    [No Abstract]   [Full Text] [Related]  

  • 3. Management of multiple myeloma.
    Malpas JS
    Br Med J; 1969 Apr; 2(5650):163-5. PubMed ID: 5778941
    [No Abstract]   [Full Text] [Related]  

  • 4. Treatment of multiple myeloma.
    Brodsky I; Kahn SB; Meyer AN
    Geriatrics; 1967 Mar; 22(3):140-8. PubMed ID: 6019488
    [No Abstract]   [Full Text] [Related]  

  • 5. Melphalan in multiple myeloma.
    Hoogstraten B; Sheehe PR; Cuttner J; Cooper T; Kyle RA; Oberfield RA; Townsend SR; Harley JB; Hayes DM; Costa G; Holland JF
    Blood; 1967 Jul; 30(1):74-83. PubMed ID: 6028709
    [No Abstract]   [Full Text] [Related]  

  • 6. [Prognosis of multiple myeloma].
    Morell A; Skvaril F; Rüst HP; Spengler GA; Brunner K; Barandun S
    Schweiz Med Wochenschr; 1970 Nov; 100(46):1990-2. PubMed ID: 5507847
    [No Abstract]   [Full Text] [Related]  

  • 7. Cyclophosphamide vs melphalan in treatment of plasma cell myeloma.
    Rivers SL; Patno ME
    JAMA; 1969 Feb; 207(7):1328-34. PubMed ID: 4179565
    [No Abstract]   [Full Text] [Related]  

  • 8. [Myelomatosis].
    Stavem P; Hjort PF
    Tidsskr Nor Laegeforen; 1969 Jun; 89(11):826-8. PubMed ID: 5793599
    [No Abstract]   [Full Text] [Related]  

  • 9. Treatment of myelomatosis--M.R.C. trial.
    Galton DA
    Br Med J; 1971 May; 2(5757):323-4. PubMed ID: 4930211
    [No Abstract]   [Full Text] [Related]  

  • 10. Multiple myeloma. II. The value of melphalan.
    Bernard DB; Lynch SR; Bothwell TH; Bezwoda WR; Stevens K; Shulman G
    S Afr Med J; 1974 May; 48(24):1026-8. PubMed ID: 4835772
    [No Abstract]   [Full Text] [Related]  

  • 11. Immunochemical classes of myelomatosis. Including data from a therapeutic trial conducted by a Medical Research Council working party.
    Hobbs JR
    Br J Haematol; 1969 Jun; 16(6):599-606. PubMed ID: 4184690
    [No Abstract]   [Full Text] [Related]  

  • 12. [Gastric localization of multiple myeloma].
    Bourreille J; Hemet J; Tayot J; Maitre AM
    Sem Hop; 1974 May; 50(25):1737-42. PubMed ID: 4369571
    [No Abstract]   [Full Text] [Related]  

  • 13. [Myeloma : symptoms, diagnosis, treatment].
    Piguet H; Borg JY; Monconduit M; Bizet M
    Rev Prat; 1979 Jan; 29(3):333-6, 339-44, 347-8. PubMed ID: 419356
    [No Abstract]   [Full Text] [Related]  

  • 14. Melphalan therapy for plasma cell myeloma.
    Alexanian R; Bergsagel DE; Migliore PJ; Vaughn WK; Howe CD
    Blood; 1968 Jan; 31(1):1-10. PubMed ID: 5638562
    [No Abstract]   [Full Text] [Related]  

  • 15. Multiple myeloma. 2. A report on sixty-seven cases.
    Hill RS; Wilson JD
    N Z Med J; 1968 Feb; 67(428):194-203. PubMed ID: 5238829
    [No Abstract]   [Full Text] [Related]  

  • 16. IgG subclasses: relationship to clinical aspects of multiple myeloma and frequency distribution among M-components.
    Schur PH; Kyle RA; Bloch KJ; Hammack WJ; Rivers SL; Sargent A; Ritchie RF; McIntyre OR; Moloney WC; Wolfson L
    Scand J Haematol; 1974; 12(1):60-8. PubMed ID: 4208834
    [No Abstract]   [Full Text] [Related]  

  • 17. Alkeran and multiple myeloma.
    Med Lett Drugs Ther; 1966 Apr; 8(8):32. PubMed ID: 5913764
    [No Abstract]   [Full Text] [Related]  

  • 18. Normal immunoglobulins in multiple myeloma: effect of melphalan chemotherapy.
    Alexanian R; Migliore PJ
    J Lab Clin Med; 1970 Feb; 75(2):225-33. PubMed ID: 5414404
    [No Abstract]   [Full Text] [Related]  

  • 19. Multiple myeloma with coexistent myelofibrosis: improvement of myelofibrosis following recovery from multiple myeloma after treatment with melphalan and prednisolone.
    Kawauchi K; Mori H; Sugiyama H; Oshimi K; Hirayama A
    Jpn J Med; 1991; 30(5):483-6. PubMed ID: 1803051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation of abnormal immunoglobulin with clinical features of myeloma.
    Arch Intern Med; 1975 Jan; 135(1):46-52. PubMed ID: 1111470
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.